Ludwig Cancer Research bestows half a billion in new funding to six eminent U.S. research institutions – Cancer research in the U.S. got a critical boost today as the six Ludwig Centers received a total of $540 million as part of a gift from Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig.
Research backs risk-reduction surgery for ovarian cancer – Scientists back preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggest it appears helpful for women at risk of getting breast cancer because of genetic faults.
Fewer Doses of HPV Vaccine Result in Immune Response Similar to Three-Dose Regimen – Two doses of a human papillomavirus (HPV) vaccine, trademarked as Cervarix, resulted in similar serum antibody levels against two of the most carcinogenic types of HPV (16 and 18), compared to a standard three dose regimen.
Compound in grapes, red wine could help treat multiple types of cancer, study finds – A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment.
Major Changes Urged for Cancer Screening and Treatment — Scientific Panel Recommends New Personalized Strategies to Reduce Cancer Overtreatment – To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
Cancer diagnosis puts people at greater risk for bankruptcy — Study also shows younger cancer patients are most vulnerable to financial stress – People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer. Younger cancer patients had two- to five-fold higher bankruptcy rates compared to older patients, and that overall bankruptcy filings increased as time passed following diagnosis.
FDA approval of generic version of cancer drug Doxil is expected to help resolve shortage – The U.S. Food and Drug Administration approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). Doxorubicin hydrochloride liposome injection is currently on the FDA?s drug shortage list.
Daily multivitamins reduce risk of cancer in men — Brigham and Women?s Hospital study is the first to examine the long-term affect of multivitamins on a major chronic diseases – A daily multivitamin can help a man reduce his risk of cancer. The Physicians’ Health Study II is the first clinical trial to test the affects of multivitamins on a major disease such as cancer.